8-K: Algorhythm Holdings Faces Nasdaq Delisting Warning

Algorhythm Holdings, Inc. received a Nasdaq delisting notice for failing to meet the minimum stockholders' equity requirement, reporting only $100,000 against a $2.5 million threshold.

Summary

• Algorhythm Holdings, Inc. (RIME) received a notice from Nasdaq Staff on November 28, 2025.
• The company failed to satisfy Nasdaq Listing Rule 5550(b)(1), which requires a minimum stockholders' equity of $2,500,000.
• As of September 30, 2025, the company's stockholders' equity was reported as $100,000.
• This notice does not immediately impact the listing of the company's common stock on Nasdaq.
• The company has 45 calendar days, until January 12, 2026, to submit a plan to regain compliance.
• If the plan is accepted, Nasdaq may grant an extension of up to 180 calendar days.
• There is no assurance that the plan will be accepted or that compliance will be regained.
• The company has the option to appeal any delisting decision to a hearings panel, which would stay the delisting action.

Sentiment

Score: 2

Explanation: The filing indicates severe financial distress with the company failing to meet Nasdaq's minimum equity requirement, leading to a delisting notice. This presents significant uncertainty and risk for investors.

Negatives

• Received a delisting notice from Nasdaq for failing to meet the minimum stockholders' equity requirement.
• Stockholders' equity of $100,000 as of September 30, 2025, is significantly below the Nasdaq minimum of $2,500,000.
• Uncertainty regarding the acceptance of the compliance plan and the ability to regain compliance within any granted extension period.

Risks

• Failure to submit an acceptable plan to regain compliance with Nasdaq's Stockholders Equity Requirement.
• Inability to evidence compliance with the Stockholders Equity Requirement even if an extension period is granted.
• Potential delisting of the company's common stock from The Nasdaq Stock Market LLC.

Future Outlook

The company plans to timely submit a plan to regain compliance with the Nasdaq Stockholders Equity Requirement by January 12, 2026. However, there is no assurance that Nasdaq will accept the plan or that the company will successfully regain compliance within any potential extension period.

Management Comments

• The Company plans to timely submit a plan to regain compliance with the Stockholders Equity Requirement for the Staff's consideration.

Industry Context

This announcement highlights the ongoing scrutiny by exchanges like Nasdaq to ensure listed companies meet minimum financial health standards. Companies with declining equity often face such notices, reflecting broader challenges in profitability or capital management within their respective sectors.

Stakeholder Impact

• Shareholders: Face significant risk of the company's common stock being delisted from Nasdaq, which could severely impact liquidity and share value.
• Creditors: May view the company's financial health with increased scrutiny due to the low stockholders' equity and compliance issues.

Next Steps

• Submit a plan to Nasdaq to regain compliance by January 12, 2026.
• Potentially receive an extension period of up to 180 calendar days from Nasdaq if the plan is accepted.
• If the plan is not accepted, the company has the opportunity to appeal the decision to a hearings panel.

Key Dates

Recommendation

The company has received a delisting notice from Nasdaq due to critically low stockholders' equity, which is 25 times below the required minimum. While there's a plan to regain compliance, the outcome is highly uncertain, and the risk of delisting is substantial. Delisting would severely impair liquidity and likely lead to a significant decline in share price, making a strong sell recommendation prudent for investors to mitigate potential losses.

Keywords

Algorhythm Holdings, RIME, Nasdaq, delisting, stockholders' equity, compliance, Form 8-K, SEC filing, financial health, listing requirements